Federal Agency Overview Lewis-Burke Associates, LLC May 2018 About - PowerPoint PPT Presentation

Federal Agency Overview Lewis-Burke Associates, LLC May 2018

About Lewis-Burke • Twenty-eight policy experts with range of expertise/backgrounds allow multi- layered issue teams with deep expertise in agencies and scientific/higher education areas • Support federal relations activities to develop and implement federal strategies to pursue, shape, and create new sources of funding to increase and diversify research portfolio • Able to engage on multiple levels: - Individual faculty (including early career faculty) - Teams of faculty - Associate Deans for Research - Deans and Center Directors - University leadership and campus-wide priorities/activities

Federal Funding: Status and Outlook • Bipartisan budget deal passed in February raised non-defense discretionary spending caps by $63 billion in FY 2018 and $69 billion in FY 2019 – Omnibus provided funding boosts NASA, NSF, DOE, NIH, DOD S&T, etc. • FY 2018 bills a far cry from President’s request: protected key programs like ARPA -E, NSF; increased funding for NIH by $3B – Delays frustrate research agencies and reduce ability to launch new programs and distribute grants: will create a flurry in late Spring/Summer – Agencies exploring Other Transaction Authorities (OTAs), additional mechanisms to get money out fast • Research Infrastructure: Mid-Scale initiative (NSF); Instrumentation grants (NIH) • Increased funding coming for FY 2019 – President’s FY 2019 Budget Request is largely irrelevant— spending caps will be similar to FY 2018 – Agencies will be managing program budgets significantly increased over current levels – Now is the time to help shape programmatic priorities and future solicitations

Snapshot of Agency Priorities

National Institutes of Health (NIH) • NIH received $3 billion increase in FY 2018, bringing the agency to $37.1 billion in total funding – Congress has thoroughly rejected Administration’s attempts to cap F&A costs on NIH grants • Current areas of trans-NIH emphasis: – Opioids, addiction, pain management ($500 million in 2018; pharma partnership on non-addictive pain meds and MAT) – Alzheimer’s Disease ($1.8 billion investment in FY 2018) – BRAIN Initiative ($400 million in FY 2018) – Precision Medicine ($290 million in FY 2018) – Cancer ($300 million in FY 2018) – Biomedical Data Science Strategic Plan • Award trends —agency focused on “research productivity and efficiencies” – Pulling back on Program Project grants (P awards) – Collaborative funding mechanisms enhance program officers’ input on project (U awards) – Next Generation Researchers Initiative: enhanced support mechanisms for early and mid-career investigators • $100 million dedicated fund within OD proposed for FY 2019 – Seeking to reduce PI salary support on grants

National Science Foundation (NSF) • FY 2018 Funding: $7.767B, increase of $295M or 3.9% over FY 2017 • FY 2019 budget request includes focus on 10 Big Ideas for Future Investment – $30M proposed for each research idea: Harnessing the Data Revolution; Future of Work at the Human-Technology Frontier; Windows on the Universe; Quantum Leap; Rules of Life; Navigating the New Arctic – New “ Convergence Accelerators ” proposed - Harnessing the Data Revolution ($30M) and Work at the Human-Technology Frontier ($30M) – Funding proposed for Process Ideas: Mid-Scale Research Infrastructure ($60M); NSF 2026 Fund ($6.5M); INCLUDES ($20M); Growing Convergence Research ($16M) – Several competitions for FY 2018: 2 Quantum Dear Colleagues, FW-HTF (LOI Due 4/16), TRIPODS+X (Proposals Due 5/29), DCL Convergence Research (due 5/1 (for FY 2018) and 10/15 (for FY 2019)); DCL Navigating the New Arctic • Large Center Awards: – STC solicitation expected to be released early CY 2019 – New ERC planning grants (Proposals due 6/6); full solicitation expected late CY 2018 • Obama-era Initiatives Winding Down: INFEWS; Risk and Resilience; Understanding the Brain; Cyber-enabled Materials, Manufacturing, and Smart Systems (CEMMSS) – What’s next? Major cross -foundational program Coastlines and People (COPE) – modeled off of SEES, focus on urban coastal • International offices closing this summer (Brussels, Tokyo, and Beijing) – expect more ad-hoc international engagement • Relatively new leadership in ENG, GEO, MPS directorates will drive new priorities: Search ongoing for BIO, SBE, EHR, and soon CISE and NSF Deputy Director

Department of Defense (DOD) • DOD received a 14.2 % increase in FY 2018, with the Research, Development, Test, and Evaluation (RDT&E) account receiving $88.3 billion, a 22.1 % increase – The Science and Technology (S&T) accounts – Basic Research (6.1), Applied Research (6.2), and Advanced Technology Development (6.3) – received $14.8 billion, a 6.1 percent increase – Basic Research received a 2.9 % increase • Advanced Technology Development and Systems Engineering continue to be major priorities as DOD is focused on READINESS and MODERNIZATION – Emphasis on use of Prototyping and Experimentation to reduce risk early in the development cycle and rapidly field new capabilities • DOD continues to consider new methods of engaging with the extramural research community, like ARL’s Open Campus Initiative a nd the Air Force’s on -going S&T study to consider new methods of conducting research – NDAA requests OSD for plan to integrate DOD labs across defense and commercial innovation hubs -- maximizing their expertise and reach • Opportunities : DURIP , MURI, Minerva, Many DARPA BAAs, CDMRP topics, DTRA BAA Major Areas of Interest : – Lethality – Strategic Weapons – Materials/Manufacturing – Hypersonics – Test and evaluation science – AI and Machine Learning – Expedited tech transition and acquisition – Space capabilities – STEM Education – Cybersecurity/Information Assurance – Autonomy and Robotics – Modeling and Simulation – Synthetic Biology and Emerging Biosciences – Trusted Micro-electronics

CDMRP – FY 2018 Topics Bolded items reflect increases in FY 2018 • Peer-Review Medical ($330 m) • Reconstructive Transplant ($12 m) • Breast Cancer ($130 m) • Trauma Clinical ($10 m) • Traumatic Brain Injury and Psychological health ($125 m) • Amyotrophic Lateral Sclerosis ($10 m) • Prostate Cancer ($100 m) • Hearing Restoration ($10 m) • Peer-Review Cancer ($80 m) • Orthotics and Prosthetics ($10 m) • Joint Warfighter Medical ($50 m) • Global HIV/AIDS prevention ($8 m) • Peer-Review Orthopedic ($30 m) • Military Burn ($8 m) • Spinal Cord ($30 m) • Epilepsy ($7.5 m) • Gulf War Illness ($21 m) • Autism Research ($7.5 m) • Ovarian Cancer ($20 m) • Tuberous Sclerosis ($6 m) • Neurotoxin Exposure Treatment Parkinson's ($16 m) • Multiple Sclerosis ($6 m) • Alzheimer’s Disease ($15 m) • Tick-Borne Disease Research ($5 m) • Kidney Cancer ($15 m) • Lupus ($5 m) • Neurofibromatosis Research ($15 m) • Alcohol and Substance Abuse ($4 m) • Vision ($15 m) • Duchenne Muscular Dystrophy ($3.2 m) • Lung Cancer Research ($14 m) • Bone Marrow Failure ($3 m) • HIV/AIDS program increase ($12.9 m)

Peer Reviewed Medical Research Program (PRMRP): FY 2018 Topics • Acute Lung Injury • Guillain-Barre Syndrome • Pressure Ulcers* • Antimicrobial Resistance • Hepatitis B and C • Pulmonary Fibrosis • Arthritis • Hereditary Angioedema • Respiratory Health • Burn Pit Exposure • Hydrocephalus • Rett Syndrome • Cardiomyopathy* • Immunomonitoring of Intestinal • Rheumatoid Arthritis Transplants • Cerebeller Ataxia* • Scleroderma • Inflammatory Bowel Diseases • Chronic Migraine and Post-Traumatic • Sleep Disorders Headaches • Interstitial Cystitis • Spinal Muscular Atrophy • Chronic Pain Management* • Lung Injury* • Sustained-release Drug Delivery • Congenital Heart Disease • Malaria • Tinnitus • Constrictive Bronchiolitis • Metals Toxicology • Tissue Regeneration • Diabetes • Mitochondrial Disease • Tuberculosis • Dystonia • Musculoskeletal Disorders • Vaccine Development for Infectious • Eating Disorders • Myotonic Dystrophy Diseases • Emerging Infectious Diseases • Nonopioid Pain Management • Vascular Malformations • Endometriosis* • Nutrition Optimization* • Women's Heart Disease • Epidermolysis Bullosa • Pancreatitis • Focal Segmental Glomerulosclerosis • Pathogen-Inactivated Blood Products • Fragile X Syndrome • Post-Traumatic Osteoarthritis * Denotes new topic in FY 2018

Department of Energy (DOE) • FY 2018 Funding: $34.5B, increase of $3.8 billion or 12% over FY 2017 • Single largest increase was for the Office of Science ($866 million or 16% above FY 2017) because of bipartisan support for basic research in the physical sciences – Top priorities: exascale computing, quantum information science, new and upgraded science facilities, stable funding for Energy Frontier Research Centers • ARPA-E is not eliminated and is increased by 16% to $353 million – Additional funding for the OPEN FOA and possible topics include long duration energy storage, energy- smart farm, high efficiency high temp modular power, high efficiency hybrid vehicles • All applied energy programs also see major increases with largest growth to nuclear energy – Five Clean Energy Manufacturing Innovation Centers and four Energy Innovation Hubs are funded and Congress calls on DOE to move forward with a fifth Hub on Desalination • Upcoming larger-scale funding opportunities: biosystems design, 2 nonproliferation university consortia, predictive science academic alliance centers, Desalination Hub, emerging building technologies for energy efficiency